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Abstract. 
 
Both cell adhesion protein CD44 and its 
main ligand hyaluronic acid (HA) are thought to be in-
volved in several processes ultimately requiring cyto-
skeleton rearrangements. Here, we show that the small 
guanine nucleotide (GTP)-binding protein, Rac1, can 
be activated upon HA binding to CD44. When applied 
locally to a passive cell edge, HA promoted the forma-
tion of lamellipodial protrusions in the direction of the 
stimulus. This process was inhibited by the prior injec-
tion of cells with dominant-negative N17Rac recombi-
nant protein or by pretreatment of cells with mono-
clonal anti-CD44 antibodies, interfering with HA 
binding, implying the direct involvement of CD44 in 
signaling to Rac1.
Key words: extracellular matrix • cell guidance • 
Rac1 • cytoskeleton • mammary epithelial cells
 
Introduction
 
A widely distributed cell adhesion protein, CD44, serves
as the major cell surface receptor for hyaluronic acid
(HA)
 
1
 
. HA is a main carbohydrate component of the ex-
tracellular matrix with a simple, repeated disaccharide lin-
ear copolymer structure. It is mostly found in skin, joints,
and eyes, but is also present in other organs and tissues.
HA expression is tightly regulated; it is elevated in a vari-
ety of inflammatory conditions (Gerdin and Hallgren,
1997). Transient overexpression of HA also takes place
in granulation tissue during the wound healing process
(Chen and Abatangelo, 1999). The biological roles attrib-
uted to HA range from a purely structural function in the
extracellular matrix to regulation of cell motility and adhe-
sion (Itano et al., 1999; Delpech et al., 1997) and receptor-
mediated alterations in gene expression (Fujii et al., 1999).
Both CD44 and HA are thought to be involved in a variety
of physiological processes, such as tumor formation and
metastasis (Günthert, 1996), wound repair (Kaya et al.,
1997), the inflammatory immune response (Günthert,
1999), lymphocyte homing and adhesion (Siegelman et
al., 1999), and embryonic development (Ponta and Herr-
lich, 1998). All these processes require concordant rear-
rangements of the actin cytoskeleton being the basis of
various cell adhesion and migration events. Yet, there is
almost no information available regarding possible intra-
cellular signals transmitted upon CD44 binding to HA.
Similarly, the exact roles of CD44 in vivo remain to be de-
termined. Here, we show that in mouse mammary epithe-
lial cells (EpH4), CD44 interaction with HA triggers the
local signaling cascade, resulting in the direct activation of
small GTP-binding protein Rac1, actin cytoskeleton rear-
rangements, and reorientation of cells in the direction of
the provided cue.
 
Materials and Methods
 
Cells, Antibodies, Reagents, and Constructs
 
Media, tissue culture reagents, and FCS were purchased from GibcoBRL
and Boehringer Mannheim Corp. EpH4 cells, a spontaneously immortal-
ized mouse mammary epithelial cell line (Fialka et al., 1996), were cul-
tured at 37
 
8
 
C in 5% CO
 
2
 
 and 98% humidity in Eagle’s medium, supple-
mented with 10 mM Hepes/KOH, pH 7.3, 50 IU/ml penicillin, 50 mg/ml
streptomycin, and 5% FCS.
Anti-CD44 antibody, KM114, blocking hyaluronate recognition by
 
J
 
The online version of this article contains supplemental material.
Address correspondence to Dr. Lukas A. Huber, IMP, Research Insti-
tute of Molecular Pathology, Dr. Bohr-Gasse 7, A-1030 Vienna, Austria.
Tel.: (
 
1
 
43)-1-79730-885. Fax: (
 
1
 
43)-1-7987-153. E-mail: huber@nt.imp.
univie.ac.at
 
1
 
Abbreviations used in this paper:
 
 EpH4, mouse mammary epithelial
cell line; HA, hyaluronic acid.
 
Brief Report 
The Journal of Cell Biology, Volume 148, 2000 1160
 
CD44, and anti-CD44 antibody, IM7.8.1, were purchased from RDI. Anti-
Rac1 antibodies were purchased from Transduction Laboratories. Oli-
gosaccharide of HA (H-9649) was purchased from Sigma Chemical Co.,
and high molecular weight HA, labeled with FITC, was a kind gift from
Dr. C. Isacke and coworkers (Imperial College, London, UK). Laminin
(20–200 
 
m
 
g/ml) and fibronectin (12–300 
 
m
 
g/ml) were from Boehringer
Mannheim. Lipofectamine PLUS™ Reagent was purchased from Gibco-
BRL. Rhodamine–phalloidin was from Molecular Probes (R-415). Re-
combinant N17Rac and N17Cdc42 were kindly provided by Dr. K. Rott-
ner (Austrian Academy of Sciences, Salzburg, Austria; using a construct
originally provided by Dr. A. Hall, University College, London, UK), dia-
lyzed into 50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM MgCl
 
2
 
, and 1 mM DTT.
Concentrations of 1–2 mg/ml were used for injections. GST-CRIB con-
struct was kindly donated by Dr. R. Cerione (Cornell University, Ithaca,
NY). Human zyxin and paxillin in pEGFP-N1 vector were kindly supplied
by Dr. J. Wehland and coworkers (GBF, Braunschweig, Germany). NH
 
2
 
-
terminal EGFP human 
 
b
 
-actin, under the control of CMV promoter,
cloned in pcDNA3 vector was kindly provided by Dr. M. Way (EMBL,
Heidelberg, Germany).
 
Microinjections and Local Applications
 
Microinjections were performed with sterile Femtotips (Eppendorf, 5242
952.008) held in a Leitz micromanipulator with a pressure supply from an
Eppendorf Microinjector 5242. Cells were injected with continuous out-
flow mode from the needle under a constant pressure of 20–40 hPa. Local
applications of HA were performed essentially as described in Kaverina
et al. (1999), under a constant pressure of 25–50 hPa.
 
Videomicroscopy
 
Cells were observed in an open chamber at 37
 
8
 
C on an inverted micro-
scope (Axiovert 135TV, Zeiss) equipped for epifluorescence and phase-
contrast microscopy. Injections were performed at 40
 
3
 
 (NA 1.3 Plan
Neofluar), and videomicroscopy with a 100
 
3
 
 (NA 1.4 Plan-Apochromat)
with or without 1.6
 
3
 
 optovar intermediate magnification. Data were ac-
quired with a back-illuminated cooled CCD camera from Princeton Re-
search Instruments driven by IPLabs software (Visitron Systems). The mi-
croscope was additionally equipped with shutters driven through a
homemade interface to allow separate recordings of video sequences in
phase-contrast and fluorescent channels. Time between frames was 18 s.
The video sequences were analyzed and processed on a Macintosh Power
PC using IPLabs and Adobe Photoshop 5.2.1 software.
 
Online Supplemental Material 
 
The online version of this article includes videos that accompany the fig-
ures presented here. Videos are supplied in the QuickTime format and
are available at http://www.jcb.org.cgi/content/full/148/6/1159/DC1.
 
Video 1. 
 
Depicts Fig. 1 a.
 
Video 2. 
 
Depicts Fig. 1 c.
 
Video 3. 
 
Depicts Fig. 2 a.
 
Video 4. 
 
Depicts Fig. 2 b.
 
Video 5. 
 
Depicts Fig. 2 b, inset.
 
Video 6. 
 
Depicts Fig. 2 c.
 
Video 7. 
 
Depicts Fig. 3 a.
 
Video 8 and the Supplemental Figure.  
 
Microinjection of the dominant-
negative N17Cdc42 recombinant protein does not block HA/CD44-
induced lamellipodial formation. EGFP-
 
b
 
-actin–expressing cell was mi-
croinjected into N17Cdc42 recombinant protein and, subsequently, treated
with HA. Note the formation of new lamellipodia in response to HA.
 
Results
 
EpH4 cells derive from a spontaneously immortalized
mouse mammary epithelial cell line and display a fully po-
larized epithelial cell phenotype when grown to high den-
sity on semipermeable filter supports or in a three-dimen-
sional collagen matrix (Fialka et al., 1996). However, when
sparsely seeded, EpH4 cells often display a fan-shaped and
motile fibroblastoid phenotype. Fibroblastoid cells typi-
cally exhibit protruding, mobile lamellipodial regions, in-
terspersed by mainly concave, inactive cell edges, delim-
 
ited by peripheral actin filament bundles (Small, 1988).
EpH4 cells express large amounts of CD44, consisting of
standard and several variant isoforms (data not shown). In
many cell types, CD44 exhibits a nonrandom distribution
in the plasma membrane. In polarized epithelial cells,
CD44 localization is restricted to the basolateral mem-
brane domain, whereas in sparsely seeded, unpolarized
EpH4 cells, CD44 is more broadly distributed, but clearly
concentrated in the trailing regions and in the cell body
(Oliferenko et al., 1999).
When sparsely seeded, EpH4 cells were treated with
soluble oligosaccharides of HA. The majority of cells
appeared depolarized, often with multiple lamellipodia
around their entire circumference. This phenomenon was
followed in more detail in single cells by phase-contrast
time-lapse microscopy. By these means, we could confirm
the fast outgrowth of new lamellipodia from cell edges
previously exhibiting an inactive actin cytoskeleton, in-
cluding trailing regions (Fig. 1 a, see also supplemental
video). We quantified the percentage of cells exhibiting
the polarized fibroblastoid phenotype in control and HA-
treated cells. Almost three quarters (69%) of sparsely
seeded EpH4 cells in control cultures exhibited unidirec-
tional movement and a polarized morphology. Already 15
min after addition of HA, only 28% EpH4 cells remained
polarized, whereas the rest exhibited multiple lamellipo-
dia. However, the proportion of polarized cells in the pres-
ence of HA was comparable to control (68%) upon pre-
treatment of cells with anti-CD44 antibody, KM114 (Fig. 1
b). This mAb efficiently inhibits binding of HA to CD44
(Miyake et al., 1990). Inhibition of HA-induced lamellipo-
dial protrusion by KM114 implied the direct involvement
of CD44 in mediating the HA effect. To evaluate changes
in the actin cytoskeleton in real time, we repeated HA
treatment on EpH4 cells transiently expressing EGFP-
 
b
 
-actin. We observed the reorganization of the actin cy-
toskeleton, new lamellipodial outgrowth, characterized by
a band of actin fluorescence, active ruffling of the leading
edges, and the appearance of very bright EGFP-actin con-
taining spots, or microruffles, on the cell surface (Fig. 1 c,
see also supplemental video).
The immediate effect of HA treatment on the cell shape
led us to investigate whether the observed changes could
be induced locally. This was tested by the local application
of HA through a microinjector needle to selected regions
of cells. When HA was applied to inactive cell edges we
could indeed observe a spatially restricted outgrowth of
lamellipodia underneath the micropipette (Fig. 2 a, see
also supplemental video). Pretreatment of cells with KM114
antibody effectively prevented these rearrangements, in a
way similar to after the general application of HA (data
not shown). HA-induced lamellipodia harbored small fo-
cal complexes that subsequently elongated and grew into
mature focal adhesions, as revealed by experiments with
cells transiently transfected with EGFP fusion constructs
of the focal adhesion proteins, zyxin (Fig. 2 b, see also sup-
plemental video) and paxillin (data not shown). Identical
results were obtained with high molecular weight HA (Fig.
2 c, see also supplemental video). The local applications of
the matrix proteins, laminin and fibronectin, under identi-
cal conditions did not produce lamellipodia outgrowth
(data not shown). 
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HA-induced cytoskeleton rearrangements were highly
reminiscent of lamellipodial protrusion and ruffling caused
by the activated GTPase Rac1 (Ridley et al., 1992), a
member of the Rho family of small GTPases (Tapon and
Hall, 1997). Rac1 is thought to be activated by various
stimuli, including growth factors (Peppelenbosch et al.,
1995; Ridley et al., 1995; Wennstrom et al., 1994; Nobes
et al., 1995). To analyze whether Rac1 is indeed involved
in HA-induced lamellipodial outgrowth, we analyzed the
effect of HA on cells injected with the mutant form of
Rac1, N17Rac, which acts as a dominant inhibitor of Rac1
activity. When cells were microinjected with N17Rac re-
combinant protein before HA treatment, the formation of
lamellipodia was efficiently blocked (Fig. 3 a, see also
supplemental video). Analysis of the effect of N17Rac
was performed in ten independent experiments; the HA-
induced lamellipodia outgrowth was inhibited in all cells
observed. Likewise, de novo–formed HA-induced lamelli-
podia were retracted when cells were injected with N17Rac
after HA treatment (data not shown). Injection of domi-
nant-negative N17Cdc42 did not prevent HA-induced
lamellipodia outgrowth, arguing for a direct effect on Rac,
rather than via Cdc42 (data not shown; see supplementary
figure and video available at http://www.jcb.org.cgi/con-
tent/full/148/6/1159/DC1).
To determine whether HA/CD44-induced lamellipodial
outgrowth could be attributed to the direct activation of
Rac1 instead of an activation of its downstream targets, we
performed an affinity pull-down assay, allowing us to di-
rectly measure the amount of the active, GTP-bound form
of Rac1 (Bagrodia et al., 1998). The CRIB domain of the
downstream Rac1 effector, PAK, specifically binds the
GTP-bound form of Rac1, which allows a quantification of
actual amounts of active Rac1 in cell lysates. The affinity
matrix, representing GST-fusion of CRIB domain coupled
to the glutathione–Sepharose beads, was incubated with
cell lysates derived from either control cells or cells
treated with HA for various times. As shown in Fig. 3 b,
the amount of GTP-bound Rac1 was considerably in-
creased already after two minutes of HA treatment, and
continued to a plateau after 15 min. However, the total
amount of Rac1 did not change upon HA treatment (Fig. 3
b). Taken together, these results argue for the direct acti-
vation of Rac1 upon HA/CD44 engagement.
 
Discussion
 
Application of soluble HA to EpH4 cells in culture pro-
moted activation of Rac1 and rapid outgrowth of lamelli-
podia from previously inactive cell edges. This effect was
dependent on the ability of CD44 to bind HA. More inter-
estingly, when HA was applied locally, a spatially re-
stricted outgrowth of lamellipodia was observed precisely
in the region of HA application. This result means that ac-
tivation of Rac1 probably takes place directly in the vicin-
ity of the plasma membrane. Rac1 activation appears to be
independent on Cdc42, since microinjection of dominant-
negative Cdc42N17 protein does not block HA-induced
lamellipodia outgrowth. HA-induced lamellipodia also con-
tained mature focal adhesions. This strongly implies that,
in this case, not only is Rac1 activated, but also that Rho
remains active.
The precise details of Rac1 activation upon HA/CD44
engagement remain to be elucidated. However, it is tempt-
ing to speculate that one of the Rac1 accessory proteins
could participate in complex formation with CD44. One
Figure 1. HA treatment promotes lamellipodial outgrowth. a, Oligosaccharide of HA (1 mg/ml) was applied to sparsely grown EpH4
cells. Note lamellipodial outgrowth from previously inactive cell edges. Numbers refer to the time, in minutes and seconds, in the time-
lapse sequence. Arrows show the area of outgrowth. b, Histogram of the number of polarized cells in control, HA-treated (HA), and
HA-treated cells preincubated with anti-CD44 HA-blocking antibodies, KM114 (KM114/HA). Mean 6 SD values are shown (n 5 200
cells, three experiments). c, Time-lapse sequence of EGFP-b-actin expressing EpH4 cells treated with HA. Note growth of lamellipodia
from inactive cell edge and appearance of multiple microruffles. Videos depicting a and c are available at http://www.jcb.org.cgi/
content/full/148/6/1159/DC1. Bar, 10 mm. 
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of the logical candidates would be the guanine nucleotide
exchange factor, Tiam-1, which was shown to specifically
activate Rac1, but not Cdc42 (Sander et al., 1999). Re-
cently, while this paper was under review procedure, the
biochemical evidence of the direct CD44/Tiam-1 interac-
tion was reported (Bourguignon et al., 2000). This result
might provide the potential straightforward link between
CD44/HA binding and Rac1 activation. CD44 was also
found in a complex with Rho-GDP dissociation inhibi-
tor (RhoGDI; Olofsson, 1999) and proteins of the ERM
(ezrin-radixin-moesin) family in fibroblasts (Hirao et al.,
1996). The interaction of ERM proteins with RhoGDI
was shown to activate Rho subfamily members (Hirao et
al., 1996; Takahashi et al., 1997). It might also be possible
that HA binding to CD44 would trigger the conforma-
tional change in this complex, inactivating RhoGDI as a
result, and ultimately contributing to the activation of
Rac1.Yet, CD44/ERM interaction appears to be rather
Figure 2. Lamellipodial outgrowth is spatially restricted and confined to the region of local HA application. When oligosaccharide HA
(40 mg/ml) was supplied through the microinjection needle to the defined region of the cell, we could observe rapid lamellipodia forma-
tion exclusively underneath the micropipette (a). The lamellipodia being formed exhibited normal focal contact formation and growth,
as shown for the EGFP-zyxin–expressing cell (b). High molecular weight HA (40 mg/ml) was equally potent in inducing local lamellipo-
dial outgrowth (c). Videos depicting A–C and the inset in B are available at http://www.jcb.org.cgi/content/full/148/6/1159/DC1. Bars:
(a–c) 10 mm, (b, inset) 5 mm. 
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cell-type restricted. So far, we have no indication that they
interact with each other in EpH4 mammary epithelial cells
(Oliferenko et al., 1999).
Interestingly, when the dominant active mutant of
Rac1 was overexpressed in human glioblastoma cells
(U251MG), CD44 was shown to redistribute to lamellipo-
dia where it subsequently was cleaved and shed from the
surface (Okamoto et al., 1999). A possible mechanism for
downregulating CD44-mediating signaling can be sug-
gested by these experiments.
The observation we describe here would suggest the
possibility of the direct involvement of CD44 and HA in
cell guidance. We would like to propose that HA may
serve as an external stimulus influencing cell orientation,
with CD44 mediating signaling to the actin cytoskeleton. 
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